Ruxolitinib for steroid-refractory acute graft-versus-host disease.

MLA

Toama, Wael, et al. “Ruxolitinib for Steroid-Refractory Acute Graft-versus-Host Disease.” Transplant International : Official Journal of the European Society for Organ Transplantation, vol. 33, no. 2, Feb. 2020, pp. 244–46. EBSCOhost, https://doi.org/10.1111/tri.13560.

APA

Toama, W., Fiala, M., Pusic, I., Westervelt, P., Dipersio, J. F., & Schroeder, M. (2020). Ruxolitinib for steroid-refractory acute graft-versus-host disease. Transplant International : Official Journal of the European Society for Organ Transplantation, 33(2), 244–246. https://doi.org/10.1111/tri.13560

Chicago

Toama, Wael, Mark Fiala, Iskra Pusic, Peter Westervelt, John F Dipersio, and Mark Schroeder. 2020. “Ruxolitinib for Steroid-Refractory Acute Graft-versus-Host Disease.” Transplant International : Official Journal of the European Society for Organ Transplantation 33 (2): 244–46. doi:10.1111/tri.13560.